Rockwell Automation and Industry Leaders Launch the Digital CMC Consortium to Accelerate Digital Transformation in Pharmaceutical Development
New industry collaboration addresses pharma's most complex development challenges and expedites patient access to breakthrough therapies MILWAUKEE, Oct. 8, 2026 /PRNewswire/ -- Rockwell Automation, Inc. (NYSE: ROK), the world's largest company dedicated to industrial automation and digital transformation, today announced it is a founding member of the Digital CMC Consortium, a not-for-profit, pre-competitive industry...
MAYBELLINE NEW YORK LAUNCHES “TOGETHER WE’RE BRAVE” CAMPAIGN FOR WORLD MENTAL HEALTH DAY
Maybelline's Brave Together Platform Introduces New Campaign That Spotlights the Power of Connection and Support in Mental Health Journeys NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Ahead of World Mental Health Day on October 10, Maybelline New York unveiled "Together We're Brave," the latest chapter of Brave Together, the brand's global...
Nuevocor Doses First Patient in SUNBEAM-LMNA Phase 1/2 Trial and Receives FDA Fast Track Designation for NVC-001 in LMNA Dilated Cardiomyopathy
NVC-001 is designed to target the mechanobiological root cause of LMNA dilated cardiomyopathy and has disease-modifying potential SINGAPORE, PARIS and PHILADELPHIA, Oct. 8, 2026 /PRNewswire/ -- Nuevocor, a clinical-stage biotechnology company pioneering mechanobiology-targeted therapies designed to address the root causes of life-threatening cardiomyopathies, today announced that the first patient has been dosed in SUNBEAM-LMNA, its first-in-human Phase 1/2...
LOTTE Biologics and Alvotech announce US-based manufacturing agreement to increase global supply
Collaboration covers multiple biosimilar products to be manufactured at LOTTE Biologics' Syracuse facility in New York Strategic long-term partnership with Alvotech to increase their global manufacturing capacity and support growth in demand SEOUL, South Korea and REYKJAVIK, Iceland, Oct. 8, 2026 /PRNewswire/ -- LOTTE Biologics, a contract development and manufacturing (CDMO) organization,...
Sisram Medical Announces Share Repurchase Plan for Up to 1% of Issued Shares
Reinforcing Confidence in Long-Term Growth and Commitment to Shareholder Returns HONG KONG, Oct. 8, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices ("EBD"), injectables, and other complementary solutions, today announced a share repurchase plan under its existing share repurchase mandate and subject to market conditions. Sisram intends to repurchase...
Löviselle LEAP Advances Across Singapore and Malaysia: Building a Regional Platform for Bio-Active Regeneration
KUALA LUMPUR, Malaysia, Oct. 8, 2026 /PRNewswire/ -- Following the inaugural LEAP at a leading Singapore Medical Academy, Löviselle convened the first Malaysian LEAP at the Medical Academy of Malaysia. Over two days, more than 60 local physicians gathered around the theme "Beyond Stimulation, True Regeneration" for academic exchange from scientific rationale to hands-on practice. Together, the Singapore...
Ribo Submits European Clinical Trial Application for Phase Ⅰ Study of INHBE-Targeting siRNA RBD3133
SUZHOU, China and MÖLNDAL, Sweden, Oct. 8, 2026 /PRNewswire/ -- Suzhou Ribo Life Science (06938.HK) and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to as "Ribo") announced the successful submission of a Phase Ⅰ Clinical Trial Application (CTA) in EU for RBD3133, a novel siRNA therapeutic targeting INHBE (inhibin subunit beta...
NCCN Highlights Collaborations to Improve Global Cancer Outcomes During Meetings in North America and Asia
National Comprehensive Cancer Network participates in annual conferences for the International Gynecologic Cancer Society and Philippine Society of Medical Oncology in efforts to standardize cancer treatment recommendations. MONTREAL and MANILA, Philippines, Oct. 8, 2026 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading academic cancer centers in the United States—is...
WuXi AppTec Earns EcoVadis Gold Medal for Third Consecutive Year, Ranking Among Global Top 5% for Sustainability
SHANGHAI, Oct. 8, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), has received a Gold medal from EcoVadis for the third consecutive year, reflecting the Company's consistent commitment to sustainability. EcoVadis is a leading sustainability rating agency for global supply chains. Its ratings assess companies based on 21 sustainability criteria...
Air Liquide to build new Air Separation Unit at its Fairfield facility in New South Wales
MELBOURNE, Australia, Oct. 8, 2026 /PRNewswire/ -- Air Liquide announces a new investment to build and operate a new Air Separation Unit (ASU) and its related infrastructure at its existing Fairfield Facility located in Yennora, New South Wales - Australia. This will enhance local supply chain reliability for industrial and medical gases across Australia. Air Liquide to...
